Would you have Dacryocystitis when you have Type 2 diabetes?
Summary: there is no Dacryocystitis reported by people with Type 2 diabetes yet.
We study people who have Dacryocystitis and Type 2 diabetes from FDA and social media. Find out below who they are, other conditions they have and drugs they take.
You are not alone: join a mobile support group for people who have Type 2 diabetes and Dacryocystitis >>>
Type 2 diabetes
Type 2 diabetes can be treated by Metformin Hydrochloride, Metformin, Glipizide, Januvia, Victoza, Janumet. (latest reports from 92,839 Type 2 Diabetes patients)
Dacryocystitis (inflammation of the lacrimal sac causing obstruction of the tube draining tears into the nose) has been reported by people with osteoporosis, hepatitis c, multiple myeloma, gouty arthritis, joint pain. (latest reports from 47 Dacryocystitis patients)
On Mar, 1, 2015: No report is found.
Do you have Type 2 Diabetes and Dacryocystitis?
You are not alone! Join a mobile support group on :
- support group for people who have Type 2 diabetes
- support group for people who have Dacryocystitis
Could your drug cause:
Other conditions that could cause:
Recent Type 2 Diabetes related drug comparison:
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.